tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HUMA Stock Latest News

Humacyte Announces $20 Million Registered Direct Offering
Company AnnouncementsHumacyte Announces $20 Million Registered Direct Offering
4d ago
8K
HUMA
Humacyte Ends ATM Program, Highlights Symvess Global Expansion
PremiumCompany Announcements
Humacyte Ends ATM Program, Highlights Symvess Global Expansion
4d ago
8K
HUMA
Humacyte prices $20M registered direct offering
PremiumThe Fly
Humacyte prices $20M registered direct offering
4d ago
HUMA
Humacyte receives Symvess purchase commitment
PremiumThe Fly
Humacyte receives Symvess purchase commitment
4d ago
HUMA
Humacyte submits MAA for Symvess in Israel for vascular trauma repair
PremiumThe Fly
Humacyte submits MAA for Symvess in Israel for vascular trauma repair
6d ago
HUMA
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
1M ago
SLS
DPRO
Humacyte announces presentation of Symvess long-term safety, efficacy results
Premium
The Fly
Humacyte announces presentation of Symvess long-term safety, efficacy results
1M ago
HUMA
Humacyte reports new DoD funding for procurement of bioengineered blood vessels
Premium
The Fly
Humacyte reports new DoD funding for procurement of bioengineered blood vessels
1M ago
HUMA
Humacyte price target lowered to $10 from $11 at Benchmark
PremiumThe Fly
Humacyte price target lowered to $10 from $11 at Benchmark
2M ago
HUMA
Humacyte announces data from analysis of charges for extremity arterial injury
PremiumThe Fly
Humacyte announces data from analysis of charges for extremity arterial injury
2M ago
HUMA
Humacyte announces planned MAA for Symvess in Israel
PremiumThe Fly
Humacyte announces planned MAA for Symvess in Israel
3M ago
HUMA
Humacyte announces long-term safety, efficacy results of Symvess
PremiumThe Fly
Humacyte announces long-term safety, efficacy results of Symvess
3M ago
HUMA
Humacyte Enters Sales Agreement with TD Securities
PremiumCompany AnnouncementsHumacyte Enters Sales Agreement with TD Securities
3M ago
8K
HUMA
Humacyte announces credit facility up to $77.5M
Premium
The Fly
Humacyte announces credit facility up to $77.5M
3M ago
HUMA
Humacyte Secures $77.5 Million Loan Facility
Premium
Company Announcements
Humacyte Secures $77.5 Million Loan Facility
3M ago
8K
HUMA
Humacyte Terminates Revenue Interest Agreement
PremiumCompany Announcements
Humacyte Terminates Revenue Interest Agreement
3M ago
8K
HUMA
Buy Rating on Humacyte Driven by Promising Clinical Data and Strong Growth Prospects
PremiumRatings
Buy Rating on Humacyte Driven by Promising Clinical Data and Strong Growth Prospects
4M ago
HUMA
Humacyte Ends Sale Agreement with Jefferies LLC
PremiumCompany Announcements
Humacyte Ends Sale Agreement with Jefferies LLC
4M ago
8K
HUMA
Humacyte’s Promising Growth in Vascular Therapy Market Justifies Buy Rating
PremiumRatings
Humacyte’s Promising Growth in Vascular Therapy Market Justifies Buy Rating
4M ago
HUMA
Humacyte announces presentations at VEITHsymposium on ATEV results
PremiumThe FlyHumacyte announces presentations at VEITHsymposium on ATEV results
4M ago
HUMA
Humacyte price target lowered to $11 from $14 at Benchmark
Premium
The Fly
Humacyte price target lowered to $11 from $14 at Benchmark
4M ago
HUMA
Positive Growth Prospects and Financial Stability Drive Buy Rating for Humacyte
Premium
Ratings
Positive Growth Prospects and Financial Stability Drive Buy Rating for Humacyte
4M ago
HUMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >